MIF exhibited a mixed pattern: high expression was linked to poor prognosis in OS and RFS (OS: HR = 1.30, RFS: HR = 1.31), while low expression was associated with worse prognosis in PPS (PPS: HR = 0.72), indicating distinct biological functions at different CRC stages. Here, MIF is linked to colorectal carcinoma.